The top three genes in the rankings were HN1, AQP3, and GSTP1. Previous research has established a significant association between AQP3 and GSTP1 and the onset, progression, and therapeutic resistance of NSCLC [63–66]. This evidence concerns the gene AQP3 and non-small cell lung carcinoma.